SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001048477-24-000013
Filing Date
2024-02-22
Accepted
2024-02-22 16:06:44
Documents
16
Period of Report
2024-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20240222.htm   iXBRL 8-K 24810
2 EX-99.1 earningsrelease-22feb24ex9.htm EX-99.1 282643
6 GRAPHIC bmrnlogoa01.jpg GRAPHIC 3615
  Complete submission text file 0001048477-24-000013.txt   465151

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20240222.xsd EX-101.SCH 2001
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20240222_lab.xml EX-101.LAB 24134
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20240222_pre.xml EX-101.PRE 12603
17 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20240222_htm.xml XML 2712
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 24664717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)